Atezolizumab plus Bevacizumab Versus Lenvatinib for Unresectable Hepatocellular Carcinoma: A Large, Real-Life, Worldwide Population.

AuthID
 P-00Z-DPY
19
Author(s)
Rimini, M
·
Casadei Gardini, A
·
Suda, G
·
Shimose, S
·
Kudo, M
·
Cheon, J
·
Rimassa, L
·
Presa, J
·
Yoo, C
·
Lonardi, S
·
Burgio, V
·
Document Type
Abstract
Year published
2023
Published
in JOURNAL OF CLINICAL ONCOLOGY, ISSN: 0732-183X
Volume: 41, Pages: 579-579 (1)
Conference
Genitourinary Cancers Symposium, Date: JAN 19-21, 2023, Location: San Francisco, CA
Indexing
Wos®
Publication Identifiers
Wos: WOS:001093994600626
Source Identifiers
ISSN: 0732-183X
Export Publication Metadata
Marked List
 Add to Marked List
Info
At this moment we don't have any links to full text documens.

A place for researchers and their institutions

Useful Links

Get Help

© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service